Novavax Inc (NVAX)
$4.46
0.13 (3.00%)
NVAX Stock Quote Delayed 30 Minutes
NVAX Stock Earnings: Novavax Beats EPS, Misses Revenue Estimates
NVAX stock earnings show that Novavax reported a narrower loss than expected but missed revenue estimates for Q1.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
332.20M
PE Ratio
-0.80
EPS
-5.56
Volume (Avg. Vol.)
590,224
Day's Range
$4.29 - $4.50
52-Week Range
$3.53 - $11.36
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
Stop! Don’t Infect Your Portfolio With Toxic Novavax Stock.
Novavax used those two dreaded words - "going concern" - and that's a signal for sensible investors to stay away from NVAX stock.
Why Is Novavax (NVAX) Stock Moving Today?
Novavax (NVAX) stock is on the move Wednesday despite a lack of news from the vaccine company and no heavy trading volume.
Short Squeeze Stocks: BBBY, SI and 3 Other Stocks Ready to Squeeze
Short squeeze stocks are all over Wall Street in the wake of the regional banking crisis. Which names should you keep an eye out for?
Why Is Novavax (NVAX) Stock Up 12% Today?
Although Novavax may have seen its shares pop higher on Friday, investors should consider the bigger picture of NVAX stock.
5 Investors Still Betting Big on Novavax (NVAX) Stock
NVAX stock is plummeting lower today after the biotechnology company reported fourth-quarter earnings and a issued going concern warning.
NVAX Stock Alert: Is Novavax Going Bankrupt?
NVAX stock is tanking after the pharma company said it might not be able to continue operations as sales of its Covid-19 vaccine are weak.
Why Is Novavax (NVAX) Stock Down 26% Today?
Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.
NVAX Stock Alert: What to Know as Novavax Names New CEO
Although a change at the top boosted sentiment for Novavax, the harsh reality is that NVAX stock faces a mountain of worries.
Three Pharma Stocks to Sell Before They Die
Small investors should not be venture capitalists, betting on companies before they have something to market, or a proven business model.
Why Is Novavax (NVAX) Stock Down 10% Today?
Novavax is conducting a public offering of 6.5 million shares. Here's why the news is pushing NVAX stock down.
Why Is Novavax (NVAX) Stock Plunging Today?
NVAX stock is down today on fundraising plans. Here's what investors should know about this once-promising Covid-19 vaccine player.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi
Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session.
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19.
